| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:59877610:3526 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:59877610:3526?format=raw |
LEADER: 03526fam a2200421 a 4500
001 4052560
005 20221027024859.0
008 960411t19961996enka b 001 0 eng d
010 $a 96157155
015 $aGB96-32205
020 $a0748405577
035 $a(OCoLC)ocm34675817
035 $9ALU2665HS
035 $a(NNC)4052560
035 $a4052560
040 $aUk$cUk$dDLC$dNNC-M$dOrLoB-B
042 $alccopycat
050 04 $aQP535.K1$bP656 1996
082 00 $a615/.7$220
245 00 $aPotassium channels and their modulators :$bfrom synthesis to clinical experience /$cedited by J.M. Evans [and others].
260 $aLondon ;$aBristol, PA :$bTaylor & Francis,$c[1996], ©1996.
300 $axiv, 424 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aThe Taylor & Francis series in pharmaceutical sciences
504 $aIncludes bibliographical references and index.
505 00 $g1.$tThe Synthesis and Chemistry of Benzopyran Related Potassium Channel Activators /$rD. G. Smith --$g2.$tStructure-Activity Relationships of Benzopyran Based Potassium Channel Activators /$rJ. M. Evans and G. Stemp --$g3.$tSyntheses and Structure-Activity Relationships of Pyridine Based Potassium Channel Activators /$rM. N. Palfreyman --$g4.$tConformational Analysis of Potassium Channel Activators /$rC. M. Edge --$g5.$tThe Structure-Activity Relationships of Potassium Channel Blockers /$rR. Crossley and A. Opalko --$g6.$tPotassium Channels: Diversity, Assembly and Differential Expression /$rR. Latorre and P. Labarca --$g7.$tPotassium Channel Electrophysiology in Vascular Smooth Muscle Cells and the Site of Action of Potassium Channel Openers /$rP. I. Aaronson and C. D. Benham --$g8.$tEffects of Potassium Channel Activators in Isolated Blood Vessels /$rU. Quast --$g9.$tIn Vivo Vascular Effects of Potassium Channel Activators /$rJ. C. Clapham --
505 80 $g10.$tCardiac Potassium Channel Modulators: Potential for Antiarrhythmic Therapy /$rM. C. Sanguinetti and J. J. Salata --$g11.$tCardioprotective Properties of Potassium Channel Modulators /$rG. J. Gross --$g12.$tPotassium Channel Activators: Airway Pharmacology and Bronchial Asthma /$rJ. R. S. Arch --$g13.$tPotassium Channels in Pancreatic [beta]-Cells: Modulation, Pharmacology and their Role in the Regulation of Insulin Secretion /$rM. J. Dunne, J. H. Jaggar, E. A. Harding, C. Kane and P. E. Squires --$g14.$tPotassium Channels and their Modulation in Urogenital Tract Smooth Muscles /$rA. F. Brading and W. H. Turner --$g15.$tPotassium Channel Modulators and the Central Nervous System /$rH. Herdon --$g16.$tPotassium Channel Modulators: Clinical Experiences and Future Prospects /$rT. J. Colatsky and T. C. Hamilton.
650 0 $aPotassium channels$xEffect of drugs on.
650 0 $aIon channels$xEffect of drugs on.$0http://id.loc.gov/authorities/subjects/sh89004275
650 2 $aAnti-Arrhythmia Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D000889Q000494
650 2 $aArrhythmias, Cardiac$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D001145Q000188
650 2 $aMyocardial Ischemia$xdrug effects.
650 2 $aPotassium Channel Blockers.$0https://id.nlm.nih.gov/mesh/D026902
653 0 $aHumans$aEffects of$aDrugs
700 1 $aEvans, J. M.$q(John M.)$0http://id.loc.gov/authorities/names/n96056309
830 0 $aTaylor & Francis series in pharmaceutical sciences.$0http://id.loc.gov/authorities/names/n96056278
852 00 $boff,hsl$hQP535.K1$iP656 1996